⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10065855 | 1.00 | — | — | |
| SCHEMBL17590427 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25381057 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL6707134 | 0.97 | — | — | |
| SCHEMBL8827755 | 0.85 | GABRR1 (0.72) | — | |
| SCHEMBL11306535 | 0.83 | APAF1 (0.36) | — | |
| SCHEMBL10308609 | 0.80 | — | — | |
| SCHEMBL22363831 | 0.80 | — | — | |
| SCHEMBL17790692 | 0.80 | — | — | |
| SCHEMBL11316232 | 0.80 | APAF1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1821 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119643733-A | Exhaled breath condensate metabolite combinations, kits and methods for predicting benign and malignant lung nodules | 华中科技大学同济医学院附属协和医院 | 2025-03-18 | — | — | CN | claimed |
| EP-2217353-B1 | METHOD FOR REMOVING CARBON DIOXIDE FROM FLUID FLOWS, IN PARTICULAR COMBUSTION EXHAUST GASES | BASF SE (DE) | 2017-01-25 | — | — | EP | claimed |
| EP-2026896-B1 | CARBON DIOXIDE ABSORBENT REQUIRING LESS REGENERATION ENERGY | BASF SE (DE) | 2016-08-03 | — | — | EP | claimed |
| US-8388738-B2 | Method for removing carbon dioxide from fluid flows, in particular combustion exhaust gases | BASF SE (DE) | 2013-03-05 | — | — | US | claimed |
| US-8034166-B2 | Carbon dioxide absorbent requiring less regeneration energy | BASF SE (DE) | 2011-10-11 | — | — | US | claimed |
| CN-102137667-A | Pharmaceutical composition comprising gaboxadol and an inhibitor of PATL or OAT | LUNDBECK & CO AS H | 2011-07-27 | — | — | CN | claimed |
| US-20100236408-A1 | METHOD FOR REMOVING CARBON DIOXIDE FROM FLUID FLOWS, IN PARTICULAR COMBUSTION EXHAUST GASES | BASF SE (DE) | 2010-09-23 | — | — | US | claimed |
| US-20090215895-A1 | Therapeutic and carrier molecules | PEPLIN BIOLIPIDS PTY LTD (AU) | 2009-08-27 | — | — | US | claimed |
| US-20090199713-A1 | CARBON DIOXIDE ABSORBENT REQUIRING LESS REGENERATION ENERGY | BASF SE (DE) | 2009-08-13 | — | — | US | claimed |
| EP-1718602-A4 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2007-12-12 | — | — | EP | claimed |
| US-7256172-B1 | Method of treatment and agents useful for same | THE UNIVERSITY OF MELBOURNE (AU) | 2007-08-14 | — | — | US | claimed |
| EP-1718602-A1 | THERAPEUTIC AND CARRIER MOLECULES | Peplin Biolipids Pty Ltd. (AU) | 2006-11-08 | — | — | EP | claimed |
| WO-2005073164-A1 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2005-08-11 | — | — | WO | claimed |
| WO-2026085582-A1 | PROTEIN CAGES | THE UNIVERSITY OF SYDNEY (AU) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2026-04-23 | — | — | US | disclosed |
| US-12605425-B2 | TNF muteins and uses thereof | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2026-04-21 | — | — | US | disclosed |
| US-5456908-A | Inhibiting cellular uptake of polyamines by contacting cells with transport inhibitory amount of polymer or copolymer of said polyamines | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1995-10-10 | — | — | US | disclosed |
| US-5410031-A | Isolated complementary DNA sequence encoding mammalian sodium dependent nucleoside cotransporter protein | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) | 1995-04-25 | — | — | US | disclosed |
| WO-1994028014-A2 | PEPTIDE INHIBITORS OF UROKINASE RECEPTOR ACTIVITY | CHIRON CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |